- 12.7k views
Role of GLP 1 RA in Weight loss
GLP-1 receptor agonists (GLP-1 RAs) play a significant role in weight loss by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which helps reduce appetite and food intake. These medications, originally developed for managing type 2 diabetes, have been shown to promote substantial weight loss in overweight and obese individuals, even in the absence of diabetes. GLP-1 RAs, such as liraglutide and semaglutide, have been approved for weight management and are often used alongside lifestyle interventions. Their effectiveness in weight loss, combined with improved metabolic control, makes them a promising treatment option for individuals struggling with obesity.
About the Speaker
Dr. Leena Mahana Kapoor
Specialist Internal Medicine and Diabetologist, Aster DM Healthcare, Dubai
Dr. Leena Mahana Kapoor, Specialist Internal Medicine and Diabetologist, Aster DM Healthcare, Dubai
Upcoming Case Discussions
Preparing your Practice for Adoption of AI
Preparing Your Practice for Adoption of AI" involves building a foundation of digital literacy, data readiness, and ethical awareness among clinicians and staff. Successful integration starts with identifying key workflows where AI can enhance efficiency, accuracy, or patient outcomes. It’s essential to choose tools that align with your practice’s goals while ensuring transparency, security, and compliance. Training, change management, and continuous evaluation are critical to fostering trust and long-term adoption. Ultimately, AI should support—not replace—the human touch in medicine.
AI in Medicine: Challenges and Opportunities
AI in Medicine: Challenges and Opportunities explores the transformative potential of artificial intelligence in improving diagnostics, treatment planning, and healthcare delivery. The session highlights how AI can enhance clinical accuracy, streamline workflows, and support personalized medicine. At the same time, it addresses key challenges such as data privacy, algorithm bias, and the need for regulatory oversight. Real-world applications and case studies illustrate both the promise and the pitfalls of integrating AI into clinical practice. This session aims to equip healthcare professionals with a balanced view of how AI can complement human expertise in medicine.
Sleep Apnea and Daytime Fatigue
Sleep Disorder Breathing is a term for a group of conditions with abnormal breathing patterns during sleep. This affects everyday functioning and well being.There are few types of SDB which include upper airways resistance, hypopnea, apnea, catathrenia and heavy snoring. People suffering with SDB can have daytime symptoms that result in poor sleep also. There can also be sleepiness, depressed mood, irritability and cognitive dysfunction.
Common Surgical Emergencies in Newborn – Case scenarios
Neonatal surgery is an emergency service; it would not be appropriate to use extremely expensive equipment and highly specialized skills for a procedure that might wait. In fact, most neonatal surgery is performed with the intention of preserving lives. New surgical techniques for the treatment of other congenital anomalies are improbable, except from the inevitable rise in operations for congenital heart disease during the newborn period. The majority of specialized neonatal surgical units have found that children do not pass away from the condition for which they were referred; instead, they pass away from severe prematurity, respiratory difficulties, and accompanying abnormalities, many of which are incurable. Any improvement in outcomes is probably going to come from ventilation.
Ayurvedic Path to Parkinson’s Relief: Research Based Perspective
Ayurvedic Path to Parkinson's Relief: A Research-Based Perspective explores how ancient Ayurvedic principles can complement modern approaches in managing Parkinson's disease. Drawing from recent clinical studies and traditional wisdom, this session delves into the use of herbal formulations, Panchakarma therapies, and lifestyle modifications to alleviate motor and non-motor symptoms. It highlights the neuroprotective potential of key herbs like Mucuna pruriens and Ashwagandha. Backed by evidence and expert insights, the session aims to bridge traditional healing with modern neurological care for holistic patient outcomes.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Leena Mahana Kapoor's Talks on Assimilate
- 07th-Mar -2025, TIME : 6:00PM TO 7:00 PM
- 0
GLP-1 receptor agonists (GLP-1 RAs) play a significant role in weight loss by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which helps reduce appetite and food intake. These medications, originally developed for managing type 2 diabetes, have been shown to promote substantial weight loss in overweight and obese individuals, even in the absence of diabetes. GLP-1 RAs, such as liraglutide and semaglutide, have been approved for weight management and are often used alongside lifestyle interventions. Their effectiveness in weight loss, combined with improved metabolic control, makes them a promising treatment option for individuals struggling with obesity.
- 07th-Mar -2025, TIME : 6:00PM TO 7:00 PM
- 0
GLP-1 receptor agonists (GLP-1 RAs) play a significant role in weight loss by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which helps reduce appetite and food intake. These medications, originally developed for managing type 2 diabetes, have been shown to promote substantial weight loss in overweight and obese individuals, even in the absence of diabetes. GLP-1 RAs, such as liraglutide and semaglutide, have been approved for weight management and are often used alongside lifestyle interventions. Their effectiveness in weight loss, combined with improved metabolic control, makes them a promising treatment option for individuals struggling with obesity.